NCT03844048

An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial

Brief summary

The purpose of this extension study is to provide venetoclax and obtain long-term safety data for subjects who continue to tolerate and derive benefit from receiving venetoclax in ongoing studies.

Interventional study

Status:
Enrolling by invitation
Conditions:
Chronic Lymphocytic Leukemia
Acute Myeloid Leukemia
Multiple Myeloma
Non-Hodgkin's Lymphoma
Acute Lymphoblastic Leukemia
Cancer
Enrollment:
550 patients
Phase:
  • 1
  • 2
  • 3
  • 4
Protocol ID:
M19-388
Allocation:
N/A
Intervention model:
Single Group Assignment
Masking:
None (Open Label)
Purpose:
Treatment

Would you like to know more about this trial?

alert image Please note, participation in the clinical trial is open to patients with the disease or condition under investigation.
Yes, please contact me

Eligibility criteria

Participant attributes:
Male and Female

Age:

N/A

Inclusion Criteria:

- Subject has been enrolled and dosed in an ongoing venetoclax study and continues to
tolerate and derive benefit from the study drug.

- Male subject agrees to refrain from sperm donation.

- Female subjects must not be pregnant or breastfeeding.

Exclusion Criteria:

- None.

All the cities where the clinical studies are located

Quebec City - G1J 1Z4
Quebec City - G1J 1Z4

Quebec